PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists
Authors:
- 1 July 2014
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 41 (6) , 464-470
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Targeting GRPR in urological cancers—from basic research to clinical applicationNature Reviews Urology, 2013
- Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide TreatmentJournal of Nuclear Medicine, 2011
- Bombesin Receptor-Mediated Imaging and Cytotoxicity: Review and Current StatusCurrent Drug Delivery, 2011
- Molecular imaging targeting peptide receptorsMethods, 2009
- [ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesProceedings of the National Academy of Sciences, 2007
- Synthesis and Evaluation of Bombesin Derivatives on the Basis of Pan-Bombesin Peptides Labeled with Indium-111, Lutetium-177, and Yttrium-90 for Targeting Bombesin Receptor-Expressing TumorsCancer Research, 2004
- High expression of peptide receptors as a novel target in gastrointestinal stromal tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Peptide Receptors as Molecular Targets for Cancer Diagnosis and TherapyEndocrine Reviews, 2003
- Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancersThe Prostate, 2000